Lack of cholinergic regulation of vasopressin and norepinephrine responses to hypertonic saline in humans
- 1 January 1995
- journal article
- clinical trial
- Published by Elsevier in Psychoneuroendocrinology
- Vol. 20 (7) , 679-691
- https://doi.org/10.1016/0306-4530(95)00026-7
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- A 30-week randomized controlled trial of high-dose tacrine in patients with Alzheimer's disease. The Tacrine Study GroupPublished by American Medical Association (AMA) ,1994
- Muscarinic and nicotinic contributions to cognitive function and cortical blood flowNeurobiology of Aging, 1992
- What is the nature of mecamylamine's antagonism of the central effects of nicotine?Biochemical Pharmacology, 1989
- Osmotic and Nonosmotic Control of Vasopressin Release in the Elderly: Effect of MetoclopramideJournal of Clinical Endocrinology & Metabolism, 1987
- Age and Alpha-2 Adrenergic Regulation of Plasma Norepinephrine Kinetics in HumansJournal of Gerontology, 1987
- Effect of Cholinergic Antagonists on Basal and Osmotically Stimulated Vasopressin Release in Compartmentalized Hypothalamo-Neurohypophysial ExplantsNeuroendocrinology, 1986
- The Compartmentalized Hypothalamo-Neurohypophysial System: Evidence for a NeurohypophysialAction of Acetylcholine on Vasopressin ReleaseNeuroendocrinology, 1985
- Vasopressin-like peptides in the rat brain: immunologic and chromatographic behavior and their response to water deprivationRegulatory Peptides, 1983
- Effects of cholinergic stimulation on pituitary hormone releasePsychoneuroendocrinology, 1982
- Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementaNature, 1980